News centre | United Kingdom

Jun 26, 2023

Charity-funded £2.4m Philips MRI Simulator set to revolutionise radiotherapy treatment for cancer patients in Yorkshire

Farnborough, United Kingdom – Royal Philips (NYSE: PHG, AEX: PHIA) – marks an exciting milestone with the launch of a new Philips MRI-Simulator at Leeds Teaching Hospitals, revolutionising radiotherapy treatment for people across Yorkshire.

Staff at Leeds Cancer Centre are celebrating the official opening of a new MRI Simulator which will revolutionise radiotherapy treatment at Leeds Teaching Hospitals NHS Trust.

In 2017, Leeds Hospitals Charity launched a £2.4 million pounds ‘MR Sim’ fundraising appeal to purchase the state-of-the-art machine. Thanks to the generosity of the people of Leeds, and significant contributions from Sovereign Health Care, the Wilby family, Caravan Guard, the Cavill family and the Scarcliffe family, the target was met in 2019.

Due to the coronavirus pandemic, installation of the machine was delayed until late 2022 and it first opened to patients in April 2023.

The radiotherapy department at Leeds Cancer Centre is one of a handful of radiotherapy departments in England to offer this cutting-edge imaging technology to benefit patients. The high-definition, high-contrast images produced by the MR Sim will enable patients to receive more precise, targeted treatments whilst reducing the risk of treatment related side-effects.

Last year, the radiotherapy department, one of the largest in Europe, delivered 80,000 treatments to almost 7,000 patients from across Yorkshire. This new technology has the potential to benefit patients with a wide range of cancers, including the head-and-neck, pelvis, and brain.

In March 2023, 47-year-old Joanna Williams from Temple Newsam was diagnosed with a brain tumour called a high grade glioma, and was among the first patients to benefit from treatment using this new equipment. 

I am about to start chemotherapy and radiotherapy treatment for my brain tumour. I recently came to the radiotherapy department at Leeds Cancer Centre to have my radiotherapy mask mould and underwent an MRI scan using the new charity-funded machine. The team told me about this new technology and how this will improve treatment and outcomes for thousands of patients who are treated in Leeds every year. I’m so grateful to everyone who has donated to help cancer patients like me. The whole experience was less daunting than my previous scans as the machine told me how long each scanning process would take. This which helped reassure me that the scan would be finished soon and made me feel calmer and more comfortable.”

For decades we have been limited to using CT scans to see the tumour and plan radiotherapy for our patients. Through ground-breaking research performed here in Leeds and other research centres across the world we are now able to use MRI scans to provide more targeted treatment. The Leeds radiotherapy team worked closely with Leeds Hospitals Charity, and world-leading industry partners to realise this project which will be transformational, allowing us to more precisely target tumours. As well as benefiting patients treated today, the MR Sim provides the opportunity for patients to participate in radiotherapy research that will help us make progress quicker and find new ways to develop “smarter, kinder” radiotherapy treatments. We are so grateful to Leeds Hospitals Charity and all of the donors for their amazing support - this would not have happened without it.”

David Sebag-Montefiore

Professor of Clinical Oncology at Leeds Teaching Hospitals NHS Trust and the University of Leeds, and Director of the Leeds Cancer Research Centre and the CRUK RadNet Centre of Excellence in Leeds

At Philips, we truly work in partnership with our customers to deliver innovative technologies that drive transformation and have a positive impact on patient outcomes. We are delighted to mark another exciting milestone with the new Philips MRI-Simulator at Leeds Teaching Hospitals; revolutionising radiotherapy treatment for people across Yorkshire.”

Stephen McMillan

Solutions Lead at Philips UK & Ireland

As the charity for Leeds Teaching Hospitals NHS Trust, we are committed to funding the best cutting-edge equipment to improve outcomes for patients. The new MR Simulator is already making a huge difference to patients undergoing radiotherapy every week by providing more targeted treatment. I would like to say a heartfelt thank you to all of our donors who contributed to this appeal, it’s thanks to your support that we’re able to help Leeds Teaching Hospitals NHS Trust provide patients with the best possible care and support.”

Esther Wakeman

CEO of Leeds Hospitals Charity is delighted that the new scanner is now benefiting cancer patients in Leeds

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at

Click here to read moreClick here to read less

About Leeds Hospitals Charity

About Leeds Hospitals Charity Leeds Hospitals Charity is the charity partner of Leeds Teaching Hospitals NHS Trust, one of the biggest healthcare trusts in Europe.


We raise funds for projects, above and beyond what the NHS can provide, to support the latest in healthcare innovation and technology, the treatment of rare conditions and to help reduce health inequalities.


Working with local communities, schools and businesses across the city and beyond, we provide £6 million in additional funding for Leeds Teaching Hospitals NHS Trust every year, supporting one million patients and their families and 22,000 NHS staff.


Leeds Hospitals Charity is a registered charity in England and Wales (1170369) and is an accredited member of the Association of Medical Research Charities (AMRC).

Click here to read moreClick here to read less

About Leeds Teaching Hospitals NHS Trust 

Leeds Teaching Hospitals is one of the largest hospitals trusts in the country. Every year the Trust provides healthcare and specialist services for people from the city of Leeds, Yorkshire and the Humber and beyond.  We play an important role in the training and education of medical, nursing and dental students, and are a centre of world-class research and pioneering new treatments.


Leeds Teaching Hospitals has a budget of £1.6 billion and employs around 22,000 people.


Our care and clinical expertise is delivered from seven hospitals on five sites, and they are all joined by our vision to be the best for specialist and integrated care.


Our staff helped to define the values and behaviours that we work to, and this is known as The Leeds Way. This forms the foundation of our culture, our ethos and how we work every day.

Click here to read moreClick here to read less

About radiotherapy research in Leeds

The Cancer Research UK RadNet Centre of Excellence in Leeds combines artificial intelligence, magnetic resonance imaging and new drugs with radiotherapy to target pelvic, liver and brain cancers. It is part of the national RadNet network.

Click here to read moreClick here to read less



Dominique Monaghan

Dominique Monaghan
UKI Communications and PR Manager

You are about to visit a Philips global content page


Media assets

Staff at Leeds Hospital celebrate the opening of the MRI simulator.

The new Philips MRI simulator situated in Leeds Hospital.

Share on social media

You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.